BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

First patient treated in Clarity's therapeutic prostate cancer trial

Clarity Pharmaceuticals recruits and treats its first patient in the therapeutic phase of its SAR-bisPSMA theranostic clinical trial SECuRE (NCT0...

October 10, 2022 | News

Australia's Paradigm Biopharmaceuticals reports positive early osteoarthritis drug trial results

Australian repurposing drug company Paradigm Biopharmaceuticals says positive clinical trial results for its osteoarthritis drug candidate indicate a poten...

October 07, 2022 | News

Rapid growth puts Australian CRO Accelagen on the map for clinical research globally

Accelagen, one of Australia's leading Contract Research Organisations, has taken new 472sqM office space in Hawthorn East following two year...

September 20, 2022 | News

Australia approved New treatment for rare cancer cholangiocarcinoma

A NEW targeted therapy to treat a rare bile duct cancer called cholangiocarcinoma has been approved for use in Australia. PEMAZYRE® (pemigat...

September 16, 2022 | News

Antengene Unveils Its First Australian Office to Continue Expanding Global Presence

The new office offers an appealing environment that will help Antengene to attract more top talents, and further accelerate its expansion in the APAC regio...

September 14, 2022 | News

Prospection partners with (MDV) to accelerate healthcare analytics globally.

Health analytics pioneer, Prospection has announced a unique global data access agreement with leading Japanese medical data company Medical Data Vision Co...

September 06, 2022 | News

APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report

Download report here https://novotech-cro.com/whitepapers/evolution-clinical-trials-asia-pacific-region-compared-us-and-eu5In addition, the GlobalData...

September 05, 2022 | News

Juniper Biologics signs exclusive license agreement with Helsinn Healthcare SA for LEDAGA® (chlormethine) in Australia, Asia and the Middle East

Giorgio Calderari, Helsinn CEO commented: "I am pleased to announce this agreement with Juniper Biologics today which further widens the geographic di...

September 02, 2022 | News

CSIRO opens 'missing link' lab to developing Australian vaccine pipeline

CSIRO, Australia’s national science agency, has opened a new $23.1 million national lab in Melbourne that will bolster the nation’s ability to ...

August 11, 2022 | News

Telix and University of Queensland-led Consortium Awarded $5M Australian Research Council (ARC) Grant

The ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR) aims to establish a manufacturing platform for new medical technolog...

August 08, 2022 | News

The Clinician and Clalit Health Services partner to drive value-based care and digital care pathway implementation in Israel

The Clinician, a global digital health innovator, has partnered with one of the largest HMOs in the world and Israel's largest healthcare o...

July 29, 2022 | News

Developing a Variant-Proof SARS-CoV-2 Vaccine: a CEPI-funded ExcellGene Partnership with Bharat Biotech and the University of Sydney

The consortium partnership strives to advance a new vaccine concept that confers highly cross-reactive protection against numerous SARS-CoV-2 variants...

July 27, 2022 | News

Ozgene and Gen-H partner on Ozgene’s new OzBIG targeted humanization capability

Ozgene and Gen-H are pleased to announce our working partnership supporting Ozgene’s new OzBIG capability. Ozgene Pty Ltd is a privately held CRO bas...

July 25, 2022 | News

uLab™ clear aligner platform is now available in Australia and New Zealand

"Our expansion to the APAC region, starting with Australia and New Zealand, shows our commitment to provide orthodontists streamlined digita...

July 22, 2022 | News

Stay Connected